Prevalence and characteristics of polycystic ovarian syndrome in women attending in outpatient department of obstetrics and gynecology of Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Keywords:Body mass index, Hirsutism, Obese, Polycystic ovary syndrome
Background: Polycystic ovary syndrome (PCOS) is a heterogenous, multifactorial, complex genetic disorder. Most commonly, it affects the females of reproductive age. This is one of the most widespread diseases across the world and if left untreated, may result in infertility and even uterine cancer.
Methods: A cross sectional observation study of 100 PCOS patients was carried out from August 2018 to July 2019 in gynecology out-patient department of Bangabandhu Sheikh Mujib medical university, Dhaka. In this study clinical, biochemical and hormonal profile of these patients were analyzed and correlation was done between clinical features and biochemical and hormonal profile.
Results: The prevalence of PCOS was 6.11% in the gynecology out-patient visits and 35.39% among infertile women. The mean age group of the patients was 24.3±5.16 SD. The mean BMI was 24.66±5.34 SD. The mean duration of infertility was 5.17 years. The prevalence of metabolic syndrome in our study was 15.0%. In this study menstrual irregularity was the most common complaint. Spearman’s correlation between various clinical and laboratory parameters showed positive correlation exists between BMI and testosterone (r=0.4824; p<0.0001).
Conclusions: The study showed that most of our polycystic ovary syndrome subjects were present with oligomenorrhea. Hirsutism and central obesity were also common presentation. Obese women with PCOS had more severe ovulatory dysfunction and need more attention for their appropriate management.
Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. Bio Med J. 2001;322:716-20.
Zaadstra BM, Seidell JC, Van Noord PA, Te Velde ER, Habbema JD, Vrieswijk B et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. Bio Med J. 1993;306:484-7.
Wang JX, Davies M, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. Bio Med J. 2000;321:1320-1.
Iuorno MJ, Nestler JE. Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol. Clin. North Am. 2001;28:153-64.
Hoeger K. Obesity and weight loss in polycystic ovary syndrome. Obstet Gynecol Clin North Am. 2001;28:85-97.
NIH. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: evidence report. J Obesity Res. 1998;6:S51-209.
Moran LJ, Hutchison Sk, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane database systemic receives. 2011;CD007506.
Teede HJ, Misso Ml, Deeks AA. Assessment and management of polycystic ovary syndrome. summary of an evidence-based guideline. Med j Aust. 2011;195;565-112.
Kovacs G, Wood, C. The current status of polycystic ovary syndrome. Aust. N Z J Obstet Gynaecol. 2001;41:65-8.
Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84:1470-4.
Jones Gl, Palep Singh M, Ledger WL, Balen AH, Jenkinson C, Campbell MJ et al. Do south Asian women with PCOS have poorer health related quality of life than Caucasian women with PCOS? A comparative crosssectional study. Health QuallIfe Outcomes. 2010;20(8):149.
Mortension M, Etormann DA, Little John E, Rosenfield RL. Asymptomatic volunteer with a polycystic ovary is a functionally distinct but heterogeneous population. J Clin Endocrinal Metab. 2009; 94(5):1579-86.
Escobar-Morreale H, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012; 19(2):207.
Choudhary N, Padmalatha V, Nagarathna R, Ram A. Prevalence of Polycystic Ovarian Syndrome in Indian Adolescents. J Pediatr Adolesc Gynecol. 2011;24(4):223-7.
Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study. Ind J Endocrinol Metab. 2012;16(2):389-92.
Garg MS, A systematic review on the prevalence and management of PCOS through dietary modifications. Int J Home Sci 2018;4(1):236-9.
Arain F, Arif N, Halepota H. Frequency and outcome of treatment in polycystic ovaries related infertility Pak J Med Sci. 2015;31(3):694-9.
Haq F, Aftab O, Rizvi J. Clinical, biochemical and ultrasonographic features of infertile women with polycystic ovarian syndrome. J Coll Physicians Surg Pak. 2007;17(2):76-80.
Fatima P, Ishrat S, Rahman D, Banu J, Deeba F, Begum N et al. Quality and quantity of infertility care in Bangladesh. Mymensingh Med J. 2015;24(1):70-3.
Sangraula H, Paudel KR, Sharma M. Dec; Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. J Nepal Med Assoc. 2009;48(176):335-9.
Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L et al. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuro Endocrinol Lett. 2007;28(6):807-10.
Kumarapeli V, SeneviratneRde A, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and ~ 239. International Journal of Home Science phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am. J Epidemiol. 2008;168(3).
Hussein B, Alalaf S. Prevalence and characteristics of polycystic ovarian syndrome in a sample of infertile Kurdish women attending IVF infertility center in maternity teaching hospital of Erbil City. Open J Obstet Gynecol. 2013;10(3):577-85.
Wijeyaratne CN, Seneviratne Rde A, Dahanayake S. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum Reprod. 2011;26(1):202-13.
Muralidhara KD, Adhikari PM, Muralidhara DV. A study on the clinical, biochemical and hormonal profile of polycystic ovary syndrome patients attending tertiary care hospital. Indian J Basic App Med Res. 2015;4(3):227-36.
Musmar S, Afaneh A, Mo’alla H. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah National university-Palestine. Reprod Biol Endocrinol. 2013;11:47.
Ramanand SJ, Ramanand JB, Ghongane BB, Patwardhan MH, Patwardhan VM, Ghanghas R et al. Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women 2with polycystic ovary syndrome. Ind J Endocr Metab. 2014;18:221-5.